Fumarate compounds, pharmaceutical compositions thereof, and methods of use
US9925191B2 · kind B2 · utility
0Cited by
2References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 19, 2016 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Jun 19, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fumarate compounds, pharmaceutical compositions comprising the fumarate compounds, and methods of using fumarate compounds and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.